Cellectis S.A. (CLLS)
NASDAQ: CLLS · Real-Time Price · USD
3.790
-0.200 (-5.01%)
Jan 30, 2026, 4:00 PM EST - Market closed

Cellectis Revenue

Cellectis had revenue of $16.73M in the quarter ending June 30, 2025, with 107.48% growth. This brings the company's revenue in the last twelve months to $56.30M, up 332.15% year-over-year. In the year 2024, Cellectis had annual revenue of $41.51M with 5,397.35% growth.

Revenue (ttm)
$56.30M
Revenue Growth
+332.15%
P/S Ratio
3.38
Revenue / Employee
$371,851
Employees
222
Market Cap
279.26M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202441.51M40.75M5,397.35%
Dec 31, 2023755.00K-18.42M-96.06%
Dec 31, 202219.17M-11.18M-36.83%
Dec 31, 202130.35M-20.71M-40.56%
Dec 31, 202051.06M35.87M236.12%
Dec 31, 201915.19M2.46M19.32%
Dec 31, 201812.73M-12.46M-49.46%
Dec 31, 201725.19M-19.62M-43.79%
Dec 31, 201644.81M-11.06M-19.79%
Dec 31, 201555.86M29.70M113.49%
Dec 31, 201426.17M18.79M254.88%
Dec 31, 20137.37M-5.40M-42.26%
Dec 31, 201212.77M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
XOMA Royalty47.11M
X4 Pharmaceuticals33.98M
Neurogene925.00K
Avalo Therapeutics192.00K
Fractyl Health3.00K
Revenue Rankings